Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2000 1
2002 1
2003 1
2004 5
2005 4
2006 9
2007 4
2008 7
2009 9
2010 3
2011 7
2012 10
2013 1
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Similar Articles for PMID: 21912636

62 results
Results by year
Filters applied: . Clear all
Page 1
Molecular refinement of clinical staging in hepatocellular carcinoma patients evaluated for potentially curative therapies.
Vitale A, Navaglia F, Ramírez Morales R, Frigo AC, Basso D, D'Amico F, Zanus G, Bonsignore P, Farinati F, Burra P, Senzolo M, Grigoletto F, Plebani M, Cillo U. Vitale A, et al. PLoS One. 2011;6(9):e23093. doi: 10.1371/journal.pone.0023093. Epub 2011 Sep 1. PLoS One. 2011. PMID: 21912636 Free PMC article. Clinical Trial.
α-fetoprotein, vascular endothelial growth factor receptor-1 and early recurrence of hepatoma.
Kamiyama T, Takahashi M, Nakanishi K, Yokoo H, Kamachi H, Kobayashi N, Ozaki M, Todo S. Kamiyama T, et al. World J Gastroenterol. 2012 Jan 28;18(4):340-8. doi: 10.3748/wjg.v18.i4.340. World J Gastroenterol. 2012. PMID: 22294840 Free PMC article.
AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T, Takahashi M, Nakagawa T, Nakanishi K, Kamachi H, Suzuki T, Shimamura T, Taniguchi M, Ozaki M, Matsushita M, Furukawa H, Todo S. Kamiyama T, et al. Ann Surg. 2006 Sep;244(3):451-63. doi: 10.1097/01.sla.0000234840.74526.2b. Ann Surg. 2006. PMID: 16926571 Free PMC article.
The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
Chen D, Xing W, Hong J, Wang M, Huang Y, Zhu C, Yuan Y, Zeng W. Chen D, et al. Ann Surg Oncol. 2012 Oct;19(11):3556-65. doi: 10.1245/s10434-012-2396-1. Epub 2012 May 17. Ann Surg Oncol. 2012. PMID: 22588469
Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y, Song T, Meng L, Wu X, Ba Y, Li Q. Zhang Y, et al. ANZ J Surg. 2009 Jan-Feb;79(1-2):62-9. doi: 10.1111/j.1445-2197.2008.04801.x. ANZ J Surg. 2009. PMID: 19183381
alpha-Fetoprotein mRNA in the circulation as a predictor of postsurgical recurrence of hepatocellular carcinoma: a prospective study.
Ijichi M, Takayama T, Matsumura M, Shiratori Y, Omata M, Makuuchi M. Ijichi M, et al. Hepatology. 2002 Apr;35(4):853-60. doi: 10.1053/jhep.2002.32100. Hepatology. 2002. PMID: 11915031
Clinical significance of alpha-fetoprotein mRNA in peripheral blood in liver resection for hepatocellular carcinoma.
Marubashi S, Nagano H, Wada H, Kobayashi S, Eguchi H, Takeda Y, Tanemura M, Umeshita K, Doki Y, Mori M. Marubashi S, et al. Ann Surg Oncol. 2011 Aug;18(8):2200-9. doi: 10.1245/s10434-011-1577-7. Epub 2011 Feb 8. Ann Surg Oncol. 2011. PMID: 21301972
Hepatic resection for "BCLC stage A" hepatocellular carcinoma. The prognostic role of alpha-fetoprotein.
Santambrogio R, Opocher E, Costa M, Barabino M, Zuin M, Bertolini E, De Filippi F, Bruno S. Santambrogio R, et al. Ann Surg Oncol. 2012 Feb;19(2):426-34. doi: 10.1245/s10434-011-1845-6. Epub 2011 Jul 6. Ann Surg Oncol. 2012. PMID: 21732145 Clinical Trial.
Serum VEGF as a tumor marker in patients with HCV-related liver cirrhosis and hepatocellular carcinoma.
Mukozu T, Nagai H, Matsui D, Kanekawa T, Sumino Y. Mukozu T, et al. Anticancer Res. 2013 Mar;33(3):1013-21. Anticancer Res. 2013. PMID: 23482775
[Correlation of perioperative alpha-fetoprotein expression in peripheral blood to recurrence of hepatocellular carcinoma].
Shi M, Zhang Y, Zhong C, Lin XJ, Zhang CQ, Li JQ. Shi M, et al. Ai Zheng. 2008 Jan;27(1):83-7. Ai Zheng. 2008. PMID: 18184471 Free article. Chinese.
62 results
Jump to page